“Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways”, JOC, vol. 6, no. 1, Jan. 2007, Accessed: Feb. 05, 2026. [Online]. Available: https://carcinogenesis.com/index.php/JOC/article/view/205